Table IV.
Classification of Guillain-Barré syndrome patients according to Brighton Collaboration Group criteria.
| Complete data (n = 173) | All patients (n = 248) | |
|---|---|---|
| Level 1 | 94 (54.4) | 94 (38) |
|
| ||
| Level 2 | 78 (45) | 141 (57) |
|
| ||
| Normal NCS | 3 (1.7) | 3 (1.2) |
|
| ||
| Normal CSF protein concentration | 75 (43.3) | 75 (30.2) |
|
| ||
| NCS missing | 0 (0) | 8 (3.2) |
|
| ||
| CSF missing and NCS consistent with GBS | 0 (0) | 55 (22.1) |
|
| ||
| Level 3 | 0 (0) | 12 (4.8) |
|
| ||
| NCS and CSF missing | 0 (0) | 11 (4.4) |
|
| ||
| Normal NCS and missing CSF | 0 (0) | 1 (0.4) |
|
| ||
| Level 4 | 1 (0.6) | 1 (0.4) |
|
| ||
| Progressive phase 28 days | 1 (0.6) | 1 (0.4) |
|
| ||
| No monophasic course | 0 (0) | 0 (0) |
CSF: cerebrospinal fluid; NCS: nerve conduction studies.